Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Current Ratio 2006-2020 | PDLI

PDL BioPharma current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
PDL BioPharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.55B $0.04B 13.21
2019-12-31 $0.31B $0.05B 6.87
2019-09-30 $0.41B $0.04B 9.94
2019-06-30 $0.40B $0.04B 10.43
2019-03-31 $0.48B $0.04B 11.02
2018-12-31 $0.52B $0.05B 9.86
2018-09-30 $0.51B $0.05B 10.88
2018-06-30 $0.51B $0.05B 11.13
2018-03-31 $0.51B $0.05B 10.03
2017-12-31 $0.64B $0.19B 3.32
2017-09-30 $0.61B $0.19B 3.16
2017-06-30 $0.54B $0.28B 1.94
2017-03-31 $0.54B $0.28B 1.98
2016-12-31 $0.40B $0.13B 3.05
2016-09-30 $0.36B $0.12B 2.92
2016-06-30 $0.32B $0.02B 14.19
2016-03-31 $0.38B $0.03B 13.04
2015-12-31 $0.28B $0.04B 7.70
2015-09-30 $0.31B $0.10B 3.24
2015-06-30 $0.37B $0.14B 2.55
2015-03-31 $0.50B $0.34B 1.46
2014-12-31 $0.36B $0.19B 1.89
2014-09-30 $0.34B $0.26B 1.31
2014-06-30 $0.23B $0.31B 0.75
2014-03-31 $0.36B $0.35B 1.03
2013-12-31 $0.11B $0.41B 0.26
2013-09-30 $0.33B $0.21B 1.59
2013-06-30 $0.28B $0.24B 1.20
2013-03-31 $0.26B $0.07B 3.76
2012-12-31 $0.18B $0.01B 17.47
2012-09-30 $0.20B $0.03B 6.28
2012-06-30 $0.24B $0.09B 2.56
2012-03-31 $0.21B $0.15B 1.38
2011-12-31 $0.23B $0.13B 1.76
2011-09-30 $0.22B $0.17B 1.26
2011-06-30 $0.21B $0.22B 0.98
2011-03-31 $0.19B $0.35B 0.53
2010-12-31 $0.29B $0.19B 1.47
2010-09-30 $0.24B $0.21B 1.13
2010-06-30 $0.24B $0.31B 0.78
2010-03-31 $0.33B $0.42B 0.80
2009-12-31 $0.32B $0.29B 1.08
2009-09-30 $0.25B $0.27B 0.94
2009-06-30 $0.21B $0.07B 3.07
2009-03-31 $0.21B $0.13B 1.61
2008-12-31 $0.18B $0.03B 5.73
2008-09-30 $0.57B $0.07B 8.34
2008-06-30 $0.50B $0.06B 7.86
2008-03-31 $0.96B $0.08B 12.12
2007-12-31 $0.72B $0.12B 5.90
2007-09-30 $0.44B $0.09B 4.95
2007-06-30 $0.42B $0.10B 4.15
2007-03-31 $0.37B $0.08B 4.42
2006-12-31 $0.38B $0.11B 3.58
2006-09-30 $0.44B $0.10B 4.37
2006-06-30 $0.46B $0.07B 6.36
2006-03-31 $0.40B $0.07B 5.87
2005-12-31 $0.38B $0.07B 5.27
2005-09-30 $0.39B $0.12B 3.32
2005-06-30 $0.23B $0.07B 3.35
2005-03-31 $0.22B $0.07B 3.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.387B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.244B 14.56
Gilead Sciences (GILD) United States $93.953B 12.18
CSL (CSLLY) Australia $87.268B 0.00
Vertex Pharmaceuticals (VRTX) United States $72.211B 49.65
Regeneron Pharmaceuticals (REGN) United States $59.851B 23.07
Illumina (ILMN) United States $53.482B 54.96
Biogen (BIIB) United States $49.195B 8.42
Seattle Genetics (SGEN) United States $26.479B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.439B 10.07
Incyte (INCY) United States $21.350B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.386B 0.00
Genmab (GMAB) Denmark $19.382B 15.96
Moderna (MRNA) United States $19.370B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.295B 174.92
Genmab (GNMSF) Denmark $18.186B 53.99
Alnylam Pharmaceuticals (ALNY) United States $15.311B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.821B 37.96
BeiGene (BGNE) Cayman Islands $12.445B 0.00
Exact Sciences (EXAS) United States $12.296B 0.00
Sarepta Therapeutics (SRPT) United States $12.257B 0.00
BioNTech SE (BNTX) Germany $10.768B 0.00
Bio-Techne Corp (TECH) United States $9.834B 64.97
QIAGEN (QGEN) Netherlands $9.798B 28.49
Horizon Therapeutics Public (HZNP) Ireland $9.367B 23.05
ARGENX SE-ADR (ARGX) Netherlands $9.141B 0.00
Guardant Health (GH) United States $8.297B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.891B 0.00
Immunomedics (IMMU) United States $7.890B 0.00
Exelixis (EXEL) United States $7.482B 26.24
Ascendis Pharma (ASND) Denmark $7.047B 0.00
Repligen (RGEN) United States $6.699B 117.50
Acceleron Pharma (XLRN) United States $5.356B 0.00
Reata Pharmaceuticals (RETA) United States $5.078B 0.00
MyoKardia (MYOK) United States $4.994B 0.00
Adaptive Biotechnologies (ADPT) United States $4.959B 0.00
Mirati Therapeutics (MRTX) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $4.411B 28.91
Global Blood Therapeutics (GBT) United States $4.303B 0.00
China Biologic Products (CBPO) China $4.256B 23.66
Ultragenyx Pharmaceutical (RARE) United States $4.242B 0.00
MorphoSys AG (MOR) Germany $4.234B 32.84
Zai Lab (ZLAB) China $3.919B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.901B 85.24
Momenta Pharmaceuticals (MNTA) United States $3.836B 0.00
Vir Biotechnology (VIR) United States $3.796B 0.00
Blueprint Medicines (BPMC) United States $3.485B 0.00
Bluebird Bio (BLUE) United States $3.432B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.276B 0.00
Halozyme Therapeutics (HALO) United States $3.255B 0.00
Amicus Therapeutics (FOLD) United States $3.208B 0.00
NeoGenomics (NEO) United States $3.006B 219.54
Arena Pharmaceuticals (ARNA) United States $2.927B 0.00
UniQure (QURE) Netherlands $2.906B 0.00
Denali Therapeutics (DNLI) United States $2.892B 0.00
Amarin (AMRN) Ireland $2.683B 0.00
Alkermes (ALKS) Ireland $2.658B 52.33
Novavax (NVAX) United States $2.635B 0.00
Viela Bio (VIE) United States $2.630B 0.00
Alector (ALEC) United States $2.588B 0.00
Insmed (INSM) United States $2.582B 0.00
Fate Therapeutics (FATE) United States $2.571B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.452B 0.00
Principia Biopharma (PRNB) United States $2.243B 0.00
Inovio Pharmaceuticals (INO) United States $2.085B 0.00
Epizyme (EPZM) United States $1.904B 0.00
Eidos Therapeutics (EIDX) United States $1.869B 0.00
Zymeworks (ZYME) Canada $1.777B 0.00
Ligand Pharmaceuticals (LGND) United States $1.682B 65.48
Adverum Biotechnologies (ADVM) United States $1.681B 0.00
Arvinas (ARVN) United States $1.679B 0.00
Sangamo Therapeutics (SGMO) United States $1.611B 0.00
REGENXBIO (RGNX) United States $1.581B 0.00
Twist Bioscience (TWST) United States $1.554B 0.00
Mesoblast (MESO) Australia $1.533B 0.00
Editas Medicine (EDIT) United States $1.532B 0.00
Akcea Therapeutics (AKCA) United States $1.524B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.507B 0.00
Intra-Cellular Therapies (ITCI) United States $1.463B 0.00
I-Mab (IMAB) China $1.384B 0.00
NGM Biopharmaceuticals (NGM) United States $1.383B 0.00
Zealand Pharma (ZEAL) Denmark $1.372B 0.00
PHARMA MAR SA (PHMMF) Spain $1.363B 0.00
Coherus BioSciences (CHRS) United States $1.358B 9.48
Beam Therapeutics (BEAM) United States $1.266B 0.00
Cytokineticsorporated (CYTK) United States $1.263B 0.00
Revance Therapeutics (RVNC) United States $1.258B 0.00
Arcus Biosciences (RCUS) United States $1.246B 0.00
Myriad Genetics (MYGN) United States $1.088B 56.12
Sorrento Therapeutics (SRNE) United States $1.084B 0.00
Mersana Therapeutics (MRSN) United States $1.072B 0.00
NextCure (NXTC) United States $0.950B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.942B 0.00
Athenex (ATNX) United States $0.936B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Intellia Therapeutics (NTLA) United States $0.917B 0.00
Compugen (CGEN) Israel $0.903B 0.00
Pharming Group (PHGUF) Netherlands $0.901B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Heska (HSKA) United States $0.817B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.802B 0.00
Cellectis S.A (CLLS) France $0.801B 0.00
Cue Biopharma (CUE) United States $0.772B 0.00
Alcobra (ARCT) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.752B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.748B 0.00
NantKwest (NK) United States $0.747B 0.00
Kadmon Holdings (KDMN) United States $0.733B 0.00
Codexis (CDXS) United States $0.726B 0.00
Morphic Holding (MORF) United States $0.697B 0.00
Retrophin (RTRX) United States $0.697B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.686B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
Castle Biosciences (CSTL) United States $0.659B 0.00
Vericel (VCEL) United States $0.646B 119.25
Sinovac Biotech (SVA) China $0.640B 17.03
Bellus Health (BLU) Canada $0.631B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Stemline Therapeutics (STML) United States $0.618B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.608B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.607B 5.20
MeiraGTx Holdings (MGTX) United States $0.597B 0.00
Scholar Rock Holding (SRRK) United States $0.576B 0.00
Frequency Therapeutics (FREQ) United States $0.562B 0.00
Athersys (ATHX) United States $0.560B 0.00
AnaptysBio (ANAB) United States $0.543B 0.00
UROGEN PHARMA (URGN) United States $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.529B 0.00
DBV Technologies S.A (DBVT) France $0.523B 0.00
AC Immune SA (ACIU) Switzerland $0.521B 0.00
VBI Vaccines (VBIV) United States $0.501B 0.00
Anika Therapeutics (ANIK) United States $0.497B 15.97
Autolus Therapeutics (AUTL) United Kingdom $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.480B 25.26
Xenon Pharmaceuticals (XENE) Canada $0.468B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Protagonist Therapeutics (PTGX) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Agenus (AGEN) United States $0.460B 0.00
Cel-Sci (CVM) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.455B 0.00
Syros Pharmaceuticals (SYRS) United States $0.446B 0.00
Intrexon (PGEN) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.425B 0.00
Seres Therapeutics (MCRB) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.415B 0.00
Merus (MRUS) Netherlands $0.414B 0.00
Albireo Pharma (ALBO) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
MiMedx (MDXG) United States $0.401B 0.00
ANI Pharmaceuticals (ANIP) United States $0.383B 7.58
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.363B 0.00
Kamada (KMDA) Israel $0.350B 14.56
Selecta Biosciences (SELB) United States $0.338B 0.00
Menlo Therapeutics (MNLO) United States $0.331B 0.00
Geron (GERN) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
OSMOTICA PHARM (OSMT) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.292B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.285B 0.00
Verastem (VSTM) United States $0.284B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Cellular Biomedicine (CBMG) United States $0.266B 0.00
Aduro Biotech (ADRO) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
Fortress Biotech (FBIO) United States $0.247B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.245B 0.00
Gritstone Oncology (GRTS) United States $0.244B 0.00
Prometic Life Sciences (LMNL) Canada $0.241B 0.00
Affimed (AFMD) Germany $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.239B 0.00
Pfenex (PFNX) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.238B 0.00
XOMA (XOMA) United States $0.226B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
Exicure (XCUR) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
IVERIC Bio (ISEE) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
Pluristem Therapeutics (PSTI) Israel $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
IBio (IBIO) United States $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
Aptinyx (APTX) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Aytu Bioscience (AYTU) United States $0.173B 0.00
Dyadic (DYAI) United States $0.166B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Cerecor (CERC) United States $0.163B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Trevena (TRVN) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Enzo Biochem (ENZ) United States $0.142B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
VolitionRX (VNRX) United States $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.127B 0.00
Palatin Technologies (PTN) United States $0.126B 3.23
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
Cyclerion Therapeutics (CYCN) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Eton Pharmaceuticals (ETON) United States $0.101B 0.00
Oncobiologics (OTLK) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
AquaBounty Technologies (AQB) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Celsion (CLSN) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Organovo Holdings (ONVO) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
DiaMedica Therapeutics (DMAC) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Apricus Biosciences (SEEL) United States $0.053B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Advaxis (ADXS) United States $0.043B 0.00
OvaScience (MLND) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.038B 0.00
Cesca Therapeutics (THMO) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
TrovaGene (CRDF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Spherix (AIKI) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
VIVUS (VVUS) United States $0.022B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00